Sreenivasaiah Menasinakai

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

Shahul Hameed P, Suresh Solapure, Vikas Patil et al. · Nature Communications · 2015 · 76 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing

Shahul Hameed P, Anandkumar Raichurkar, Prashanti Madhavapeddi et al. · ACS Medicinal Chemistry Letters · 2014 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against <i>Mycobacterium tuberculosis</i>

Shahul Hameed P, Vikas Patil, Suresh Solapure et al. · Journal of Medicinal Chemistry · 2014 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target

Sudha Ravishankar, Anisha Ambady, Disha Awasthy et al. · Tuberculosis · 2015 · 49 citations

Medicine, Medicinal Chemistry, Molecular Biology +9

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy

Ramesh R. Kale, Manoj Kale, David Waterson et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9